The CyGene products are the first predictive DNA tests for the Russian market, the Company noted in a release.
CyGene currently markets a variety of DNA predictive genetic test panels that provide consumers with information on genetic predisposition to treatable conditions. The Company said that it is the only consumer genetic testing provider that guarantees anonymity to its customers, while providing access to the most updated science at the lowest possible price.
"We have great expectations for these new-age products that help consumers learn about themselves and make smart choices about their lifestyles," said Dmitri Nefedov, CEO of CyGene Russia at the company's inauguration party in Khabarovsk City. "The Russian people are eager to embrace the benefits that the next generation genetic technologies have to offer. We predict great success in this venture due to CyGene's superior business model and the ethical, cost-effective manner of introducing the science behind these products to the benefit of our citizens."
Martin Munzer, CyGene's president and CEO, said, "We believe CyGene Russia will make a significant contribution to CyGene's commercial success. Mr. Nefedov has the long-term vision and leadership to successfully introduce our products and technologies into the highly receptive and educated Russian market."
((Comments on this story may be sent to health@closeupmedia.com))

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index